ranbaxy (Emkay) Base business improves, Maintain Hold

Revenue growth led by improvement in base business; Future growth will be a combination of successful monetization of key products and pick-up in the base business
Date Rating Target Price Recommendation Price Broker house
11 May 2011 hold 412 478 Emkay Report

No comments:

Post a Comment